Gelest Upgrades and Expands Organosilane Antimicrobial Manufacturing
Gelest, Inc. announced it has significantly upgraded and expanded the manufacturing and formulation capabilities for its BIOSAFE® organosilane antimicrobial product line, dramatically improving efficiency and enabling supply with greater economies of scale.
“In response to the surging demand, we’ve refocused our efforts to make the synthesis and formulation of organosilane antimicrobials competitive at scale,” said Daria Long, Gelest Vice President of Consumer Care and Life Sciences. “New efficiencies and the upgraded capabilities put Gelest in a position to supply major users of this long-trusted technology.” The emphasis on scale and economy also prepares the BIOSAFE organosilane antimicrobial product line for widespread application rather than limiting it to a specialty niche chemistry.